LIFCO-B Stock Analysis: Lifco (publ) | ST
Conglomerates | ST, Sweden | Market Cap: 149.801m SEK | 12M Return: -0.5% | SE0015949201 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 123M
EPS Trend: 95.5%
Qual. Beats: -3
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Lifco AB is a Swedish industrial conglomerate operating across three main business areas: dental products and services, demolition and tools, and systems solutions. The dental segment distributes consumables such as denture attachments, disinfectants, impression materials, and bonding agents, while also developing medical record systems and operating dental laboratories. The demolition and tools division manufactures demolition robots, forest machines, and crane and excavator attachments for industries including construction, forestry, cement, and nuclear. The systems solutions segment covers a broad range of niche industrial products, from electrical installation equipment and recycling machinery to infrastructure products (electrification, LED-lighting, lightning protection, telecommunication) and specialty items such as coffee machines and aircraft ground service equipment.
The company sells in over 30 countries, with its largest markets in Sweden, Germany, the UK, Italy, and North America. Lifco follows a decentralized acquisition-driven model, acquiring and holding niche industrial businesses with strong market positions and recurring revenue, which is a common approach among Swedish industrial conglomerates. Founded in 1946 and headquartered in Enköping, Sweden, Lifco is controlled by Carl Bennet AB, a privately held Swedish investment company associated with industrialist Carl Bennet.
- Acquisition-driven EBITDA growth across dental and demolition segments
- Demolition robots and demolition tools drive margin expansion
- Serial acquirer model supported by stable Swedish krona and European construction demand
| Net Income: 3.85b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.78 > 1.0 |
| NWC/Revenue: -2.38% < 20% (prev -5.89%; Δ 3.52% < -1%) |
| CFO/TA 0.12 > 3% & CFO 5.23b > Net Income 3.85b |
| Net Debt (11.9b) to EBITDA (7.37b): 1.61 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (454.2m) vs 12m ago -0.17% < -2% |
| Gross Margin: 44.13% > 18% (prev 43.91%; Δ 0.22% > 0.5%) |
| Asset Turnover: 69.90% > 50% (prev 68.14%; Δ 1.76% > 0%) |
| Interest Coverage Ratio: 14.32 > 6 (EBIT TTM 5.43b / Interest Expense TTM 379.0m) |
| A: -0.02 (Total Current Assets 11.8b - Total Current Liabilities 12.4b) / Total Assets 43.7b |
| B: 0.44 (Retained Earnings 19.0b / Total Assets 43.7b) |
| C: 0.13 (EBIT TTM 5.43b / Avg Total Assets 41.9b) |
| D: 0.88 (Book Value of Equity 20.3b / Total Liabilities 23.2b) |
| Altman-Z'' = 3.11 = A |
| DSRI: 1.06 (Receivables 5.65b/4.96b, Revenue 29.3b/27.3b) |
| GMI: 1.00 (GM 43.91% / 44.13%) |
| AQI: 0.99 (AQ_t 0.65 / AQ_t-1 0.66) |
| SGI: 1.07 (Revenue 29.3b / 27.3b) |
| TATA: -0.03 (NI 3.85b - CFO 5.23b) / TA 43.7b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at SEK 329.20 with a total of 527,652 shares traded. Over the past week, the price has changed by +4.31%, over one month by +7.58%, over three months by -1.67% and over the past year by -0.51%.
Current recommended Stop Loss: 320.40 (which is 2.7% or 1.3 ATR below the current price).
Lifco (publ) has no consensus analysts rating.
P/E Trailing = 38.9374
P/E Forward = 31.4465
P/S = 5.0519
P/B = 7.0653
Revenue TTM = 29.3b SEK
EBIT TTM = 5.43b SEK
EBITDA TTM = 7.37b SEK
Long Term Debt = 5.38b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 6.71b SEK (from shortTermDebt, last quarter)
Debt = 13.2b SEK (from shortLongTermDebtTotal, last quarter) + Leases 1.32b
Net Debt = 11.9b SEK (calculated: Debt 13.2b - CCE 1.34b)
Enterprise Value = 162b SEK (150b + Debt 13.2b - CCE 1.34b)
Interest Coverage Ratio = 14.32 (Ebit TTM 5.43b / Interest Expense TTM 379.0m)
EV/FCF = 33.61x (Enterprise Value 162b / FCF TTM 4.81b)
FCF Yield = 2.98% (FCF TTM 4.81b / Enterprise Value 162b)
FCF Margin = 16.44% (FCF TTM 4.81b / Revenue TTM 29.3b)
Net Margin = 13.17% (Net Income TTM 3.85b / Revenue TTM 29.3b)
Gross Margin = 44.13% ((Revenue TTM 29.3b - Cost of Revenue TTM 16.3b) / Revenue TTM)
Gross Margin QoQ = 44.60% (prev 44.41%)
Tobins Q-Ratio = 3.70 (Enterprise Value 162b / Total Assets 43.7b)
Interest Expense / Debt = 2.87% (Interest Expense 379.0m / Debt 13.2b)
Taxrate = 23.02% (1.16b / 5.05b)
NOPAT = 4.18b (EBIT 5.43b * (1 - 23.02%))
Current Ratio = 0.94 (Total Current Assets 11.8b / Total Current Liabilities 12.4b)
Debt / Equity = 0.65 (Debt 13.2b / totalStockholderEquity, last quarter 20.3b)
Debt / EBITDA = 1.61 (Net Debt 11.9b / EBITDA 7.37b)
Debt / FCF = 2.47 (Net Debt 11.9b / FCF TTM 4.81b)
Total Stockholder Equity = 19.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.21% (Net Income 3.85b / Total Assets 43.7b)
RoE = 19.63% (Net Income TTM 3.85b / Total Stockholder Equity 19.6b)
RoCE = 21.71% (EBIT 5.43b / Capital Employed (Equity 19.6b + L.T.Debt 5.38b))
RoIC = 11.42% (NOPAT 4.18b / Invested Capital 36.6b)
WACC = 8.04% (E(150b)/V(163b) * Re(8.55%) + D(13.2b)/V(163b) * Rd(2.87%) * (1-Tc(0.23)))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 23.03 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈4.53b ; Y1≈5.19b ; Y5≈7.63b
[DCF] Fair Price = 243.1 (EV 115b - Net Debt 11.9b = Equity 103b / Shares 423.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.53 | EPS CAGR: 7.38% | SUE: -1.40 | # QB: -3
Revenue Correlation: 99.32 | Revenue CAGR: 7.73% | SUE: 0.41 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.50 | Chg30d=+0.59% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=10.29 | Chg30d=+4.85% | Revisions=+40% | GrowthEPS=+27.4% | GrowthRev=+8.7%
EPS next Year (2027-12-31): EPS=11.49 | Chg30d=+5.60% | Revisions=+40% | GrowthEPS=+11.7% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +38% (up=4, down=1)